Marqeta Inc vs Smith & Nephew plc — how do they compare? Marqeta Inc trades at $17.22 (market cap $1.85B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Smith & Nephew plc is far larger — about 6.8× Marqeta Inc's market cap, and Smith & Nephew plc pays a 2.57% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.
| MQ | SNN | |
|---|---|---|
Market Cap | $1.85B | $12.64B |
Sector | Technology | Health |
52-Week High | $27.32 | $38.70 |
52-Week Low | $15.04 | $28.73 |
Enterprise Value | $1.15B | $15.41B |
Dividend Yield | — | 2.57% |
Trailing returns across standard periods
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →